Share This:
Search Results
The DNTP Technical Report (TR) Level of Evidence Criteria are available here: https://ntp.niehs.nih.gov/go/baresults. In the table below this information is further delineated into three fields:
- Level of Evidence: The overall category of evidence of carcinogenic activity for the TR, Species, Strain and Sex
- Organ Site Call: The level of evidence supported by the specific organ site for the TR, Species, Strain and Sex. When the Organ Site Call directly supports the TR Level Of Evidence the Finding Type flag is set to “Neoplastic Lesion”. Some Organ Site Calls could support a separate call of Equivocal Evidence; this is noted in Finding Type by the flag “May Have Been Related”
- Finding Type: Further identification of the Organ Site Call. Where this says “Neoplastic Lesion” the Organ Site Call supports the TR Level of Evidence and the Organ Site Call is the same as that of the TR. Where Finding Type says “May Have Been Related” the TR Level of Evidence for other responses led to an overall call of Clear or Some Evidence but the specified organ supports a call of Equivocal Evidence.
Exact Match | Publication No. | CASRN | Test Article Name | Species | Strain | Sex | Route | Organ | Level of Evidence | Organ Site Call | Tumor Type/Incidence | Finding Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | TR-033 | 961-11-5 | Tetrachlorvinphos | Rats | Osborne Mendel | Female | Dosed-Feed | Adrenal Gland Cortex | Positive | Positive | ADENOMA | Neoplastic Lesions |
Yes | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Female | Inhalation | Adrenal Gland Cortex | Positive | Positive | ADENOMA 0/50 7/50 5/48 | Neoplastic Lesions |
Yes | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | ADENOMA OR CARCINOMA 0/52 2/55 1/53 0/53 1/53 1/52 4/53 3/50 | May Have Been Related |
Yes | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Mice | B6C3F1 | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | ADENOMA 0/50 3/49 4/48 | May Have Been Related |
Yes | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | Adenoma 1/50 1/50 3/50 4/49 | May Have Been Related |
Exact Match | Publication No. | CASRN | Test Article Name | Species | Strain | Sex | Route | Organ | Level of Evidence | Organ Site Call | Tumor Type/Incidence | Finding Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Female | Inhalation | Adrenal Gland Cortex | Positive | Positive | ADENOMA 0/50 7/50 5/48 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Mice | B6C3F1 | Female | Inhalation | Lung | Positive | Positive | ALVEOLAR/BRONCHIOLAR ADENOMA 3/49 3/49 10/47; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/49 2/49 4/47 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Mice | B6C3F1 | Male | Inhalation | Lung | Positive | Positive | ALVEOLAR/BRONCHIOLAR ADENOMA 0/41 1/40 6/45; ALVEOLAR/BRONCHIOLAR CARCINOMA 0/41 2/40 1/45 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Mice | B6C3F1 | Female | Inhalation | Nasal Cavity | Positive | Positive | BENIGN AND MALIGNANT TUMORS 0/50 11/50 38/50 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Mice | B6C3F1 | Male | Inhalation | Nasal Cavity | Positive | Positive | BENIGN AND MALIGNANT TUMORS 0/45 1/42 21/48 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Female | Inhalation | Nasal Cavity | Positive | Positive | BENIGN AND MALIGNANT TUMORS 1/50 21/50 32/50 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Male | Inhalation | Nasal Cavity | Positive | Positive | BENIGN AND MALIGNANT TUMORS 0/50 32/50 39/49 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Female | Inhalation | Oral Cavity | Positive | Positive | SQUAMOUS CELL PAPILLOMA 0/50 3/50 11/50; SQUAMOUS CELL CARCINOMA 0/50 1/50 5/50 | Neoplastic Lesions |
No | TR-206 | 96-12-8 | 1,2-Dibromo-3-chloropropane | Rats | F344/N | Male | Inhalation | Oral Cavity | Positive | Positive | SQUAMOUS CELL PAPILLOMA 0/50 1/50 8/49; SQUAMOUS CELL CARCINOMA 0/50 0/50 3/49 | Neoplastic Lesions |
Yes | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | Adenoma 1/50 1/50 3/50 4/49 | May Have Been Related |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | All Organs | Clear Evidence | Equivocal Evidence | Malignant Lymphoma: 2/50 5/50 8/50 7/50 | May Have Been Related |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | Forestomach | Clear Evidence | Clear Evidence | Squamous cell carcinoma 0/50 1/50 1/50 4/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Male | Gavage | Forestomach | Clear Evidence | Clear Evidence | Squamous cell carcinoma 0/50 1/50 1/49 3/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Forestomach | Clear Evidence | Clear Evidence | Squamous cell papilloma or carcinoma 0/50 1/50 0/50 4/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Liver | Clear Evidence | Clear Evidence | Cholangiocarcinoma 1/50 1/50 1/49 3/49 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Male | Gavage | Liver | Clear Evidence | Clear Evidence | Cholangiocarcinoma 0/50 4/50 4/50 6/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | Lung | Clear Evidence | Clear Evidence | Alveolar/bronchiolar adenoma or carcinoma 0/49 2/50 1/50 4/50 alveolar/bronchiolar adenoma or carcinoma 3/49 8/50 5/50 10/50 cystic keratinizing epithelioma 0/49 0/50 0/50 2/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Male | Gavage | Lung | Clear Evidence | Clear Evidence | Alveolar/bronchiolar adenoma 5/50 16/50 12/49 6/50 alveolar/bronchiolar adenoma or carcinoma 7/50 17/50 15/49 6/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Lung | Clear Evidence | Clear Evidence | Cystic keratinizing epithelioma 0/50 6/50 26/49 39/49 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Male | Gavage | Lung | Clear Evidence | Clear Evidence | Cystic keratinizing epithelioma 0/50 14/50 31/50 37/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Female | Gavage | Oral Cavity | Clear Evidence | Clear Evidence | Mucosa: Gingival squamous cell carcinoma 0/50 0/50 4/50 6/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Male | Gavage | Oral Cavity | Clear Evidence | Clear Evidence | Mucosa: Gingival squamous cell carcinoma 1/50 5/50 4/50 5/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | Skin | Clear Evidence | Clear Evidence | Fibrosarcoma 1/50 6/50 5/50 8/50 fibrosarcoma or malignant schwannoma 2/50 8/50 7/50 12/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Male | Gavage | Thoracic Cavity | Clear Evidence | Equivocal Evidence | Malignant Schwannoma: 0/50 0/50 1/50 3/50 | May Have Been Related |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Rats | Harlan Sprague-Dawley | Male | Gavage | Thyroid Gland Follicular Cell | Clear Evidence | Clear Evidence | adenoma 0/50 3/50 4/50 4/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | Ureter | Clear Evidence | Equivocal Evidence | Transitional epithelial carcinoma: 0/0 0/1 0/0 1/2 | May Have Been Related |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Male | Gavage | Ureter | Clear Evidence | Equivocal Evidence | Transitional epithelial carcinoma: 0/43 0/45 1/47 0/50 | May Have Been Related |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Female | Gavage | Urinary System | Clear Evidence | Clear Evidence | Urethra: Transitional epithelial gland carcinoma 0/50 0/50 0/50 2/50 | Neoplastic Lesions |
No | TR-558 | 14047-09-7 | 3,3',4,4'-Tetrachloroazobenzene | Mice | B6C3F1/N | Male | Gavage | Urinary System | Clear Evidence | Clear Evidence | Urethra: Transitional epithelial gland carcinoma 0/50 32/50 46/49 49/50 | Neoplastic Lesions |
No | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Mice | B6C3F1 | Male | Gavage | Unspecified | Inadequate Study | Not applicable | Not applicable | |
No | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Rats | F344/N | Female | Gavage | Unspecified | Inadequate Study | Not applicable | Not applicable | |
No | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Rats | F344/N | Male | Gavage | Unspecified | Inadequate Study | Not applicable | Not applicable | |
Yes | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Mice | B6C3F1 | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | ADENOMA 0/50 3/49 4/48 | May Have Been Related |
No | TR-303 | 100-40-3 | 4-Vinylcyclohexene | Mice | B6C3F1 | Female | Gavage | Ovary | Clear Evidence | Clear Evidence | GRANULOSA CELL TUMOR 1/49 9/48 11/47 OR CARCINOMA 0/49 1/48 2/47 COMBINED 1/49 10/48 13/47 | Neoplastic Lesions |
No | TR-033 | 961-11-5 | Tetrachlorvinphos | Rats | Osborne Mendel | Male | Dosed-Feed | Unspecified | Negative | Not applicable | Not applicable | |
Yes | TR-033 | 961-11-5 | Tetrachlorvinphos | Rats | Osborne Mendel | Female | Dosed-Feed | Adrenal Gland Cortex | Positive | Positive | ADENOMA | Neoplastic Lesions |
No | TR-033 | 961-11-5 | Tetrachlorvinphos | Mice | B6C3F1 | Female | Dosed-Feed | Liver | Positive | Positive | (NEOPLASTIC NODULE) | Neoplastic Lesions |
No | TR-033 | 961-11-5 | Tetrachlorvinphos | Mice | B6C3F1 | Male | Dosed-Feed | Liver | Positive | Positive | (CARCINOMA) | Neoplastic Lesions |
No | TR-033 | 961-11-5 | Tetrachlorvinphos | Rats | Osborne Mendel | Female | Dosed-Feed | Thyroid Gland C-Cell | Positive | Positive | ADENOMA | Neoplastic Lesions |
Yes | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Adrenal Gland Cortex | Clear Evidence | Equivocal Evidence | ADENOMA OR CARCINOMA 0/52 2/55 1/53 0/53 1/53 1/52 4/53 3/50 | May Have Been Related |
No | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Liver | Clear Evidence | Equivocal Evidence | CHOLANGIOMA 0/53 0/55 0/53 0/53 0/53 1/51 1/53 0/50 | May Have Been Related |
No | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Liver | Clear Evidence | Clear Evidence | CHOLANGIOCARCINOMA 0/53 0/55 1/53 0/53 5/53 6/51 22/53 2/50 OR ADENOMA 1/53 2/55 1/53 0/53 2/53 4/51 7/53 0/50 OR HEPATOCHOLANGIOMA 0/53 0/55 0/53 0/53 0/53 0/51 3/53 0/50 | Neoplastic Lesions |
No | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Lung | Clear Evidence | Clear Evidence | CYSTIC KERATINIZING EPITHELIOMA 0/53 0/55 0/53 0/53 1/53 11/51 35/51 0/50 OR SQUAMOUS CELL CARCINOMA 0/53 0/55 0/53 0/53 0/53 1/51 2/51 0/50 | Neoplastic Lesions |
No | TR-520 | 57465-28-8 | Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) | Rats | Harlan Sprague-Dawley | Female | Gavage | Oral Cavity | Clear Evidence | Clear Evidence | GINGIVAL SQUAMOUS CELL CARINOMA (ORAL MUCOSA) 0/53 1/55 1/53 1/53 2/53 2/53 7/53 2/50 | Neoplastic Lesions |